FOUNDATION FOR CONTROL OF HIV DRUG… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

JOHN MELLORS MD

Phone

4123835350

Tax Period

2024-01-01 to 2024-05-15

FOUNDATION FOR CONTROL OF HIV DRUG RESISTANCE, founded in 2003, is a micro nonprofit that reported $5K in total revenue in fiscal year 2024. Revenue fell 98% from the prior year — a significant decline worth monitoring. Expenses of $279K exceeded revenue, resulting in a 5306% operating deficit.

Mission

THE FOUNDATION FOR CONTROL OF HIV DRUG RESISTANCE IS ORGANIZED TO ENCOURAGE THE ADVANCEMENT OF SCIENCE, DISSEMINATE EDUCATION INFORMATION AND TO PROVIDE A FORUM FOR WORLD-WIDE RESEARCHERS TO GATHER AND COLLABORATE SCIENTIFIC EFFORTS ALL IN THE CRUSADE TO COMBAT DRUG RESISTANCE TO THERAPIES FOR HIV AND HEPATITIS VIRUSES. IN SUPPORT OF THIS GOAL THE FOUNDATION PLANS AND HOSTS THE ANNUAL HIV AND HEPATITIS DRUG RESISTANCE WORKSHOP AND CURATIVE STRATEGIES MEETING.

Program Service Accomplishments

Program 1

Expenses: $262,206

FOUNDATION FOR CONTROL OF HIV DRUG RESISTANCE WAS DISSOLVED IN MAY 2024.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $5,158

Other Revenue $0

TOTAL REVENUE $5,158

Expense Breakdown

Grants Paid $250,066

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $262,206

Other Expenses $28,785

TOTAL EXPENSES $278,851

Year-over-Year Comparison

	2024	2023	Change
Revenue	$5,158	$207,395	-1.0%
Expenses	$278,851	$296,022	-0.1%
Net Income	$-273,693	$-88,627	+2.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOHN MELLORS MD	DIRECTOR	0.50	Director	$0	$0	$0
DOUGLAS RICHMAN MD	DIRECTOR	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$5,158	$278,851	No data	$-273,693
2023	$207,395	$296,022	$367,687	$-88,627
2019	$227,440	$205,787	$449,487	$21,653
2018	$135,377	$158,697	$427,484	$-23,320

FOUNDATION FOR CONTROL OF HIV DRUG RESISTANCE